2024. Long-Term Efficacy of Abrocitinib in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE EXTEND. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s329. DOI:https://doi.org/10.25251/skin.8.supp.329.